Utilization of Clinical Trial Imaging for Accurate Psoriasis Area and Severity Index Prediction
Researchers leverage longitudinal imaging data from the Ultima 2 clinical trial involving patients with psoriasis undergoing treatment.
Researchers leverage longitudinal imaging data from the Ultima 2 clinical trial involving patients with psoriasis undergoing treatment.
The 2024 AAD Innovation Academy meeting is scheduled to take place August 1-4, in Seattle, Washington. Discover the latest research and innovations across a broad…
A recent survey conducted by the American Academy of Dermatology (AAD) highlighted the heightened risk of sunburn and skin cancer faced by outdoor workers in…
In a comparison of pediatric dermatologists versus AI, dermatologists primarily exhibited greater performance.
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Sunday, June 2, 2024 | 6:45 pm – 8:15 pm CT Supported by an independent educational grant from Takeda Pharmaceuticals, Inc. Join us in Chicago…
According to results from the ongoing phase 1 TROPION-PanTumor01 trial, datopotamab deruxtecan demonstrated promising efficacy and safety among heavily pretreated patients with advanced or metastatic…
Mark Lebwohl, MD, and Saakshi Khattri, MD, discuss the evolving landscape of plaque psoriasis treatments over the past year.
A 5-expert panel continues their conversation on atopic dermatitis, exploring beyond steroids and addressing unmet needs.
Drs Michaella Alexandrou and Athanasios Rempakos present key takeaways from their article, “Interventional Cardiologists’ Perspectives and Knowledge Towards Artificial Intelligence”.
This case series describes the clinical features, antifungal susceptibility, and genome sequencing of Trichophyton indotineae in 11 patients in New York City.